$1.54
+0.05 (+3.36%)
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,849.4% upside
Low Target
$30.66
Average Target
$45.42
High Target
$56.99
Current Price
$1.54
Current
$1.54
$1.54
Target
$45.42
$45.42
$30.66
$45.42 avg
$56.99
Scenario Analysis
Bear Case
$30.66
1,890.9%
Low target
Base Case
$45.42
+2,849.4%
Avg target
Bull Case
$56.99
+3,600.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$13.48
-88.6% from high
52-Week Low
$0.89
+73.0% from low
Target vs 52W High
$45.42
+236.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |